Jersey City, NJ – March 5, 2025 – Quarks Advantage, a high-tech consulting firm dedicated to developing impactful solutions across various industries, is proud to announce its continued success and expansion in improving maternal and infant health through the NurtureNJ Initiative. The company’s latest milestone is receiving the Commission on Science, Innovation, and Technology (CSIT) Award, which was announced by First Lady Tammy Murphy and New Jersey Economic Development Authority (NJEDA) CEO Tim Sullivan. This significant grant will enable Quarks Advantage to build upon its existing achievements, enhancing its core healthcare platform, Maternity Connect, and advancing other ambitious research projects.
Maternity Connect, one of Quarks Advantage’s flagship offerings, is a web-based mobile application powered by artificial intelligence that provides vital resources and support for mothers and infants from pregnancy through the first two years of life. Its features include breastfeeding coaching, vaccination tracking, and an accessible platform for connecting mothers within a broader community network. By offering these tools in an intuitive and interactive manner, Maternity Connect helps address practical challenges faced by new and expecting mothers, such as finding accurate health information, navigating postpartum care, and building stronger support systems.
With the support of the NurtureNJ Initiative and the CSIT Award, Quarks Advantage aims to expand Maternity Connect’s reach by developing a fully interactive platform that mothers across New Jersey can access 24/7, year-round. This platform will not only bolster direct communication between healthcare professionals and mothers, but also facilitate early detection of potential risk factors and connect families to essential care resources. The grant further validates the company’s innovative approach and fuels its ability to form strategic partnerships. These partnerships will be crucial in bridging gaps in care, reducing inequities, and ultimately fostering healthier communities throughout the state.
“We are truly honored to be part of the NurtureNJ Initiative and to receive the CSIT Award,” said Dr. Jose Gabriel Carrasco R. PhD, CEO of Quarks Advantage. “This support enables us to help more families through an advanced, AI-driven platform that can adapt to the evolving needs of mothers and infants. We believe that by combining cutting-edge technology with a holistic approach to healthcare, we can create lasting benefits for our communities.”
Beyond maternal and infant health, Quarks Advantage is also applying its multidisciplinary expertise to address broader challenges in biomedicine and beyond. Two of its leading research proposals, TRACE-AI and NeuroFLARE, exemplify the company’s commitment to tackling pressing issues with state-of-the-art technology:
- TRACE-AI: A groundbreaking platform for risk prediction using artificial intelligence, TRACE-AI leverages 3D liver, brain, and lung organoids to model organ-specific effects. By integrating single-cell multi-omics analyses (combining m6A-seq, ATAC-seq, and CUT&Tag) with CRISPR-based RNA editing (dCas13-METTL3), TRACE-AI aims to validate functional mechanisms that could revolutionize toxicology, disease modeling, and preventive medicine.
- NeuroFLARE: Addressing the urgent need for effective treatments in neurodegenerative disorders, NeuroFLARE employs techniques such as graph neural networks, federated learning, and adversarial molecule generation. By focusing on Alzheimer’s disease drug discovery, NeuroFLARE paves the way for novel therapies that push the boundaries of traditional biomedical research.
Each of these endeavors demonstrates Quarks Advantage’s unwavering commitment to real-world impact. By combining pioneering research with practical, community-centered solutions, the company continues to shape the future of healthcare, harnessing the power of emerging technologies while maintaining a human-centered perspective.
Moving forward, Quarks Advantage is set to deepen its collaborative ties within the Garden State’s thriving innovation ecosystem. With facilities in Jersey City and Princeton, the company stands poised to scale its initiatives further, partnering with key stakeholders in government, academia, and the private sector. The NurtureNJ Initiative’s support will be a catalyst for ensuring better health outcomes for mothers, infants, and communities across New Jersey.
About Quarks Advantage
Quarks Advantage is a high-tech consulting firm that harnesses strategic planning and cutting-edge research to develop practical, impactful solutions. By bridging technology with everyday needs, the company has pioneered a suite of AI-driven platforms for sustainable business growth—such as Improvement Business Path, LeadersTeach, and NFTR—while advancing healthcare through Maternity Connect. It also develops leading-edge research tools for health and biotechnology, including TRACE-AI and NeuroFLARE, and implements strategic solutions for coastal resilience through OceanComprehensive.
Beyond its core platforms, Quarks Advantage actively promotes quantum computing and telecommunications to empower high-speed data processing and improved connectivity, focusing on nanotechnology and innovative materials to strengthen industrial applications. The company’s tailored healthcare and life sciences solutions support advances in research and patient care, and its commitment to clean energy drives the development of sustainable technologies for a greener, more resilient future. By integrating these diverse fields into cohesive strategies, Quarks Advantage consistently delivers real-world impact in industries across the globe.
